Please login to the form below
Striverdi
This page shows the latest Striverdi news and features for those working in and with pharma, biotech and healthcare.
Boehringer COPD drug 'could give patients more independence'
Spiolto - which combines the active ingredients in Boehringer's long-acting muscarinic antagonist Spiriva (tiotropium) and long-acting beta agonist Striverdi (olodaterol) - was recently approved for marketing in the EU and
Latest news
-
Boehringer's Spiriva combo approved in first EU markets
s recently launched Striverdi product.
-
Boehringer bags FDA approval for Spiriva-based combo
Stiolto contains the active ingredient in Spiriva - long-acting muscarinic antagonist (LAMA) tiotropium - with long-acting beta agonist (LABA) olodaterol that is sold as a monotherapy under the Striverdi brand name.
-
FDA approves Boehringer COPD spray Striverdi Respimat
FDA approves Boehringer COPD spray Striverdi Respimat. Licence from US regulator will also allow it to treat chronic bronchitis or emphysema. ... Boehringer Ingelheim's once-daily chronic obstructive pulmonary disease (COPD) spray Striverdi Respimat
-
Boehringer submits COPD combo in EU
The drug combines Boehringer's huge selling Spiriva (tiotropium) with another of its respiratory treatments Striverdi (olodaterol). ... Striverdi is yet to hit the same lofty heights as Spiriva, having only received approval earlier this year.
-
Novartis, Boehringer stake claims to combination COPD market
up that combines tiotropium with the company's long-acting beta agonist Striverdi (olodaterol).
More from news
Approximately 2 fully matching, plus 5 partially matching documents found.
Featured jobs
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
- Scientific Director / Editorial Team Leader
-
Great salary and benefits
-
Medical/ Scientific Director
-
Salary TBC
- Leadership opportunity, Pricing & Market Access, UK, Substan...
-
Substantial six figure package
-
Senior Medical Writer
-
Competitive Salary
-
Medical Writers
-
Competitive Salary and Benefits
-
Associate Director
-
£75, 000-90, 000
- Director, Market Access / HEOR - North-West
-
Negotiable
- Events Manager – Med Comms – Surrey
-
Salary TBC
-
Account Director
-
£48, 000 - £60, 000
-
Account Director
-
Excellent benefits
-
Senior Medical Writer
-
Great salary and benefits
- Senior Account Director development role to Business Director, H...
-
Excellent package
-
Consumer Health Account Director
-
Circa £60, 000 Gym and More
- Senior Account Executive, London, Medical Communications
-
Excellent package
-
New Business Director - PR
-
Competitive Salary and benefits
Subscribe to our email news alerts
- Beta Thalassemia Testing Market Report Explored in Latest Research 2016-2026
- Three steps forward, four steps back
- World Diabetes Day: Interaction and impact of diabetes on mental health
- Biomaterial In Surgical Mesh Market 10-Year Market Forecast and Trends Analysis Research Report
- Inherited Orphan Blood Disorders Therapeutics Market: Segments, Opportunity, Growth and Forecast By End-use Industry 2017-2027
- Women’s Health Diagnostic Testing Market Global Industry Analysis, size, share and Forecast 2017-2027
PMHub
Skills in Healthcare
At Skills in Healthcare, we are able to provide our customers with a professional set of sales capabilities. With our...
Latest intelligence
- World Diabetes Day: Interaction and impact of diabetes on mental health
- For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
- Innovation in merger control and the impact on the pharmaceutical sector
- Is focusing on pipeline products enough to assess regulatory risks?...
- Nudge-nudge, think-think
- Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
Quick links
Infographics
